Literature DB >> 12384834

Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.

Nikos Papadogiannakis1, Thomas Tolfvenstam, Björn Fischler, Oscar Norbeck, Kristina Broliden.   

Abstract

We report a case of fulminant myocarditis in an 11-month-old female infant who had no other clinical signs of parvovirus infection. The patient presented with severe respiratory distress and died in sudden cardiac arrest 3 h after admission. The clinical presentation was similar to that of an asthmatic attack. Autopsy revealed signs of acute lymphocytic myocarditis. Parvovirus DNA was demonstrated by polymerase chain reaction (PCR) analysis of tissue sections obtained from the heart, lungs, liver, kidneys, and spleen. Transmission electron microscopy of myocardial tissue showed crystalline arrays with the appearance of parvovirus. The results of immunohistochemical analysis for the detection of parvovirus antigens were negative, and no viral inclusions were demonstrable. We suggest that the current diagnostic procedure underestimates the prevalence of parvovirus-associated myocarditis. PCR analysis should be used as a complement in suspected cases, to enhance the rate of detection of the infection and to reach a correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384834     DOI: 10.1086/342574

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Parvovirus B19 myocarditis causes significant morbidity and mortality in children.

Authors:  Kimberly M Molina; Xiomara Garcia; Susan W Denfield; Yuxin Fan; William R Morrow; Jeffrey A Towbin; Elizabeth A Frazier; David P Nelson
Journal:  Pediatr Cardiol       Date:  2012-08-08       Impact factor: 1.655

2.  SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA.

Authors:  Ayman K Johargy
Journal:  J Family Community Med       Date:  2009-09

3.  Human parvovirus B19: a mechanistic overview of infection and DNA replication.

Authors:  Yong Luo; Jianming Qiu
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

4.  Parvovirus-mediated fetal cardiomyopathy with atrioventricular nodal disease.

Authors:  Shira G Fishman; Linda M Pelaez; Rebecca N Baergen; Sheila J Carroll
Journal:  Pediatr Cardiol       Date:  2010-10-12       Impact factor: 1.655

5.  Parvovirus B19-induced apoptosis of hepatocytes.

Authors:  Brian D Poole; Yuory V Karetnyi; Stanley J Naides
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 6.  Viral myocarditis: diagnosis, aetiology and management.

Authors:  Uwe Kühl; Heinz-Peter Schultheiss
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

7.  Fatal parvovirus B19 infections: a report of two autopsy cases.

Authors:  Hsuan-Yun Hu; Shyh-Yuh Wei; Wei-Hsiang Huang; Chih-Hsin Pan
Journal:  Int J Legal Med       Date:  2018-09-01       Impact factor: 2.686

8.  A Conserved Receptor-Binding Domain in the VP1u of Primate Erythroparvoviruses Determines the Marked Tropism for Erythroid Cells.

Authors:  Cornelia Bircher; Jan Bieri; Ruben Assaraf; Remo Leisi; Carlos Ros
Journal:  Viruses       Date:  2022-02-17       Impact factor: 5.048

Review 9.  Parvovirus B19-Associated Myocarditis: A Literature Review of Pediatric Cases.

Authors:  Stergiani Keramari; Alexandros Poutoglidis; Stefanos Chatzis; Michael Keramaris; Christos Savopoulos; Georgia Kaiafa
Journal:  Cureus       Date:  2022-01-30

10.  Seroprevalence of erythrovirus B19 in Saudi pregnant women.

Authors:  Ayman K Johargy
Journal:  J Family Community Med       Date:  2016 May-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.